Skip to content

FDA OKs Amneal’s generic Lidoderm Patch

August 25, 2020

The FDA approves Amneal Pharmaceuticals’ (AMRX +1.1%) marketing application for its generic version of Endo Pharmaceuticals’ (ENDP -1.2%) Lidoderm Patch, 5% for the treatment of post-herpetic neuralgia.

Per IQVIA, the U.S. market is ~$282M.

https://seekingalpha.com/news/3608586-fda-oks-amneals-generic-lidoderm-patch

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: